Loading...
XNAS
SKIN
Market cap186mUSD
Dec 05, Last price  
1.46USD
1D
-7.59%
1Q
-28.78%
IPO
-85.64%
Name

Beauty Health Co

Chart & Performance

D1W1MN
XNAS:SKIN chart
P/E
P/S
0.56
EPS
Div Yield, %
Shrs. gr., 5y
34.70%
Rev. gr., 5y
14.94%
Revenues
334m
-16.00%
112,310,000166,623,000119,092,000260,086,000365,876,000397,991,000334,294,000
Net income
-29m
L-70.94%
-317,000-1,638,000-29,175,000-375,108,00044,224,000-100,116,000-29,098,000
CFO
16m
-25.82%
-895,0001,728,000-12,436,000-28,361,000-106,600,00021,750,00016,134,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
IPO date
Feb 10, 2020
Employees
1,034
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT